Cardiac allograft hypertrophy is associated with impaired exercise tolerance after heart transplantation

Eugenia Raichlin1, Malik A Al-Omari, Courtney L Hayes

  • 1Division of Cardiology, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Insights

Concentric hypertrophy (CH) after heart transplantation (HTx) significantly impairs exercise capacity. Identifying CH early may improve functional outcomes in transplant recipients.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Exercise Physiology

Background:

  • Exercise performance is crucial for quality of life but often limited post-heart transplantation (HTx).
  • Cardiac allograft remodeling, specifically left ventricle mass and relative wall thickness, may influence functional capacity.
  • Understanding these changes is vital for improving patient outcomes.

Purpose of the Study:

  • To investigate the impact of cardiac allograft remodeling on functional capacity in heart transplant recipients.
  • To determine the relationship between specific geometric patterns (normal geometry, concentric remodeling, concentric hypertrophy) and exercise tolerance.
  • To identify potential mechanisms for exercise limitation after HTx.

Main Methods:

  • Echocardiography was used to classify 117 heart transplant recipients into normal geometry (NG), concentric remodeling (CR), or concentric hypertrophy (CH) groups at 1 year post-transplant.
  • Cardiopulmonary exercise testing was performed to assess exercise tolerance.
  • Patients with acute rejection or graft vasculopathy were excluded.

Main Results:

  • At 1 year post-HTx, 30% of patients exhibited CH, 55% CR, and 15% NG.
  • The CH group showed significantly impaired exercise tolerance, including lower peak oxygen uptake (Vo2) and higher ventilatory equivalents for carbon dioxide (Ve/Vco2), compared to the NG group.
  • A 1-year CH pattern was independently associated with reduced normalized peak Vo2 and elevated Ve/Vco2, increasing the risk for poor exercise capacity.

Conclusions:

  • Concentric hypertrophy (CH) at 1 year post-heart transplantation is independently linked to decreased exercise capacity and altered ventilatory response.
  • CH represents a potentially reversible factor contributing to exercise limitation in stable heart transplant recipients.
  • Early identification of CH could have significant clinical implications for managing functional capacity after HTx.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...